GSA Capital Partners LLP bought a new position in Global Cord Blood Corp (NYSE:CO) in the second quarter, HoldingsChannel.com reports. The firm bought 12,054 shares of the medical research company’s stock, valued at approximately $114,000.
Other hedge funds have also recently modified their holdings of the company. Millennium Management LLC boosted its holdings in shares of Global Cord Blood by 49.3% during the 1st quarter. Millennium Management LLC now owns 164,781 shares of the medical research company’s stock worth $1,681,000 after buying an additional 54,406 shares in the last quarter. Cubist Systematic Strategies LLC bought a new position in shares of Global Cord Blood during the 1st quarter worth approximately $151,000. Element Capital Management LLC bought a new position in shares of Global Cord Blood during the 1st quarter worth approximately $205,000. Dumac Inc. bought a new position in shares of Global Cord Blood during the 1st quarter worth approximately $285,000. Finally, Commonwealth Equity Services LLC bought a new position in shares of Global Cord Blood during the 1st quarter worth approximately $117,000. Institutional investors own 18.85% of the company’s stock.
Global Cord Blood stock opened at $6.50 on Thursday. The company has a market cap of $773.08 million, a price-to-earnings ratio of 20.68 and a beta of 0.37. Global Cord Blood Corp has a 52-week low of $6.30 and a 52-week high of $12.44.
Global Cord Blood (NYSE:CO) last posted its quarterly earnings results on Thursday, August 23rd. The medical research company reported $0.09 earnings per share (EPS) for the quarter. The firm had revenue of $35.34 million for the quarter. Global Cord Blood had a return on equity of 7.79% and a net margin of 25.36%.
Global Cord Blood Profile
Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services.
Featured Story: Do Tariffs Work?
Want to see what other hedge funds are holding CO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Global Cord Blood Corp (NYSE:CO).
Receive News & Ratings for Global Cord Blood Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Cord Blood and related companies with MarketBeat.com's FREE daily email newsletter.